Prognostic value, clinical effectiveness and cost-effectiveness of high sensitivity C-reactive protein as a marker in primary prevention of major cardiac events

BACKGROUND: In a substantial portion of patients (= 25%) with coronary heart disease (CHD), a myocardial infarction or sudden cardiac death without prior symptoms is the first manifestation of disease. The use of new risk predictors for CHD such as the high-sensitivity C-reactive Protein (hs-CRP) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Schnell-Inderst, Petra, Schwarzer, Ruth, Göhler, Alexander, Grandi, Norma, Grabein, Kristin, Stollenwerk, Björn, Klauß, Volker, Wasem, Jürgen, Siebert, Uwe
Formato: Texto
Lenguaje:English
Publicado: German Medical Science GMS Publishing House 2009
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3011282/
https://www.ncbi.nlm.nih.gov/pubmed/21289893
http://dx.doi.org/10.3205/hta000068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3011282/
https://www.ncbi.nlm.nih.gov/pubmed/21289893
http://dx.doi.org/10.3205/hta000068

Ejemplares similares